Litcius/Paper detail

Prasugrel-based de-escalation of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (HOST-REDUCE-POLYTECH-ACS): an open-label, multicentre, non-inferiority randomised trial

Hyo‐Soo Kim, Jeehoon Kang, Doyeon Hwang, Jung‐Kyu Han, Han‐Mo Yang, Hyun‐Jae Kang, Bon‐Kwon Koo, Jay Young Rhew, Kook Jin Chun, Young‐Hyo Lim, Jung Min Bong, Jang‐Whan Bae, Bong Ki Lee, Kyung Woo Park

2020The Lancet198 citationsDOI

Topics & Concepts

MedicinePrasugrelAcute coronary syndromePercutaneous coronary interventionInternal medicineClinical endpointMyocardial infarctionConventional PCIAspirinRandomized controlled trialCardiologyAntiplatelet Therapy and Cardiovascular DiseasesAcute Myocardial Infarction ResearchAtrial Fibrillation Management and Outcomes